PubMed Health⌕ Search

Biomedical subjects

J Birch

Publications and source records attributed to J Birch.

At least 19 recordsLinked to original sources
PubMed2006

A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1.

Equine herpesvirus 1 (EHV-1) causes respiratory and neurological disease and abortion in horses. Animals with high frequencies of cytotoxic T lymphocytes (CTL) show reduced severity of respiratory disease and frequency of abortion, probably by CTL-mediated control of cell-associated viraemia. This study aimed to identify CTL epitopes restricted by selected major histocompatibility complex (MHC) class I alleles expressed in the equine leukocyte antigen (ELA) A3 haplotype. Effector CTL were induced from EHV-1-primed ponies and thoroughbreds with characterized MHC class I haplotypes and screened against P815 target cells transfected with selected EHV-1 genes and MHC class I genes. Targets that expressed EHV-1 gene 64 and the MHC B2 gene were lysed by effector CTL in a genetically restricted manner. There was no T-cell recognition of targets expressing either the MHC B2 gene and EHV-1 genes 2, 12, 14, 16, 35, 63 or 69, or the MHC C1 gene and EHV-1 genes 12, 14, 16 or 64. A vaccinia virus vector encoding gene 64 (NYVAC-64) was also investigated. Using lymphocytes from ELA-A3 horses, the recombinant NYVAC-64 virus induced effector CTL that lysed EHV-1-infected target cells; the recombinant virus also supplied a functional peptide that was expressed by target cells and recognized in an MHC-restricted fashion by CTL induced with EHV-1. This construct may therefore be used to determine the antigenicity of EHV-1 gene 64 for other MHC haplotypes. These techniques are broadly applicable to the identification of additional CTL target proteins and their presenting MHC alleles, not only for EHV-1, but for other equine viruses.

Alleles↗
PubMed2005

An open study to determine the efficacy of blue light in the treatment of mild to moderate acne.

BACKGROUND: The effective management of acne remains a challenge; achieving an optimal response whilst minimizing adverse events is often difficult. The rise in antibiotic resistance threatens to reduce the future usefulness of the current mainstay of therapy. The need for alternative therapies remains important. Phototherapy has previously been shown to be effective in acne, with renewed interest as both endogenous and exogenous photodynamic therapies are demonstrated for this condition. OBJECTIVES: To determine the effect of narrowband blue light in the reduction of inflammatory and non-inflammatory lesions in patients with mild to moderate acne and to evaluate patient tolerance of the therapy. METHODS: We performed an open study utilizing a blue LED light source in 30 subjects with mild to moderate facial acne. Two weeks after screening, lesions were counted and recorded by lesion type. Over 4 weeks, patients received eight 10- or 20-minute light treatments, peak wavelength 409-419 nm at 40 mW/cm2. Assessments were taken at weeks 5, 8 and 12 and lesion counts were recorded. Repeated measures-ANOVA and Dunnett's tests, respectively, allowed assessment of the different scores over time and permitted comparison of mean counts. RESULTS: An overall effect on inflammatory counts was observed at week 5, and a statistically significant decrease in inflamed counts was detected at the week 8 assessments, which continued to week 12. There was little effect on non-inflamed lesions. The treatment was well tolerated with adverse events experienced generally rated as being mild and usually self-limiting. CONCLUSIONS: Eight 10- or 20-minute treatments over 4 weeks with a narrowband blue light was found to be effective in reducing the number of inflamed lesions in subjects with mild to moderate acne. The treatment had little effect on the number of comedones. The onset of the effect was observable at the first assessment, at week 5, and maximal between weeks 8 and 12. Blue light phototherapy using a narrowband LED light source appears to be a safe and effective additional therapy for mild to moderate acne.

Acne Vulgaris↗
PubMed2002

Acquired colour vision deficiency in patients receiving digoxin maintenance therapy.

BACKGROUND/AIMS: Disturbances of colour vision are a frequently reported sign of digoxin toxicity. The aim of this study was to investigate the incidence of acquired colour vision deficiency in elderly hospitalised patients receiving maintenance digoxin therapy. METHODS: 30 patients (mean age 81.3 (SD 6.1) years) receiving digoxin were tested using a battery of colour vision tests (Ishihara, AO Hardy Rand Rittler plates, City tritan test, Lanthony tritan album, and the Farnsworth D15). These were compared to an age matched control group. Serum digoxin concentrations were determined from venous blood samples. RESULTS: Slight to moderate red-green impairment was found in approximately 20-30% of patients taking digitalis, and approximately 20% showed a severe tritan deficiency. There was no correlation between colour vision impairment and serum digoxin level. CONCLUSIONS: Formal colour vision testing of elderly patients taking digitalis showed a high incidence of colour deficiency, suggesting that impairment of retinal function can occur even at therapeutic drug levels. As a result, colour vision testing in this population would have limited value for the detection of drug toxicity.

Aged↗
PubMed2001

The response of GS-NS0 myeloma cells to pH shifts and pH perturbations.

The perceived sensitivity of animal cells to hydrodynamic shear has limited agitation and aeration at large-scale. This makes it difficult to ensure adequate mixing of the vessel contents and may lead to inhomogeneities in operational parameters such as temperature, dissolved oxygen concentration, and especially pH. The effect of pH shifts and pH perturbations on the cellular responses, in batch culture, of a GS-NS0 mouse myeloma cell line, expressing a recombinant antibody, was investigated. In addition, the effect of extreme pH on the structure of the purified antibody product was studied using isoelectric focusing. The fermentation pH value was shifted abruptly from pH 7.3 to pH values ranging from 6.5 to 9.0. Culture pH was maintained at this new value for the remainder of the fermentation. All pH shifts of above 0.2 units caused a transient increase in apoptosis. However, cultures shifted to pH values between 7.0 and 8.0 continued to grow and the apoptotic fraction returned to initial levels. Cultures shifted to pH values above pH 8.0 and below pH 7.0 did not recover resulting in culture death. For example, a shift to pH 8.5 caused accumulation of cells in the G(2)/M phase of the cell cycle followed by apoptotic death. After the pH shift, maximum specific growth rate was observed over the range pH 7.3 to 7.5 and maximum viable cell number was seen at pH 7.3. Maximum volumetric antibody production, resulting from increased culture longevity, was seen at pH 7.0. It was also observed that glucose consumption increased with increasing pH. In a separate set of experiments cells were subjected to a single pH perturbation ranging in duration from 0 to 600 minutes. Exposure of cells to a pH value greater than 8.5 for more than 10 minutes caused a decrease in the proportion of viable cells and induced a lag in cell growth. At very low pH (6.5) similar effects were seen, but only for extended perturbations (600 min). However, after recovery from the pH perturbation, growth, product secretion and metabolism all returned to original levels. Incubation of the antibody, at the range of pH values investigated, indicated no alterations in the structure of the antibody as determined by the isoelectric focusing pattern.

Animals↗
PubMed2001

Expression of aromatase in the human growth plate.

Aromatase catalyzes the synthesis of estrogen from its androgen precursors. Estrogen is known to be important in regulating long bone growth and epiphyseal plate closure. To assess whether there may be growth plate-specific production of estrogen, we performed reverse transcriptase polymerase chain reaction (RT-PCR) to determine whether aromatase transcripts are present in the human growth plate. Immunohistochemistry was also employed to identify the specific sites of expression. Growth plates were obtained from an adolescent male and female undergoing ephysectomy to counter premature growth plate closure in the opposite leg. Aromatase transcripts were detected in RNA preparations from both growth plates. The aromatase protein was mainly expressed in the zone of maturation and the hypertrophic zone, with greatest expression in the latter. Since estrogen receptors are known to be expressed in chondrocytes, this data is consistent with a role for local estrogen production in the autocrine/paracrine control of long bone growth and growth plate maturation.

Adolescent↗
PubMed2000

Increasing incidence of oral cancer amongst young persons: what is the aetiology?

The reasons for an increasing incidence of oral cancer, particularly amongst younger persons is unclear. It has been hypothesised either to be a result of an increase in exposure to known risk factors amongst certain groups in the community, or to be due to new aetiological agents. Prior to conducting large expensive population-based studies, it seems appropriate to conduct initial smaller-scale surveys to assess evidence for each of these two hypotheses. This survey of young persons with oral cancer suggest that most are exposed to traditional risk factors of tobacco smoking, drinking alcohol and a low consumption of fruit and vegetables.

Adolescent↗
PubMed2000

Doctors and the assessment of blood glucose testing sticks: does colour blindness matter?

A group of doctors with congenital colour vision deficiency (CCVD) were compared with a group of controls in their assessment of colour blocks in the colour range of a widely available blood glucose testing stick. The majority of doctors with CCVD agreed with controls on colour matching. However, subjects with severe CCVD tended to match test blocks to a wider range of options than either those with a less severe defect or controls. This paper discusses the implications of these findings.

Adult↗
PubMed1999

Performance of red-green color deficient subjects on the Holmes-Wright lantern (Type A) in photopic viewing.

BACKGROUND: The Holmes-Wright lantern (Type A) is an approved occupational color vision test for airline pilots in the European Economic Community and for specific occupations in the British Armed Forces. The colors shown are red, green and white signal lights. HYPOTHESIS: The Holmes-Wright lantern is a sensitive screening test for red-green color deficiency in photopic viewing and the pass/fail level is similar to that of the Farnsworth Lantern (Falant) if the same scoring method is applied. METHOD: There were 138 color deficient subjects identified with the Ishihara plates and diagnosed with the Nagel anomaloscope, completed a color vision test battery which included three runs of the nine color pairs of the Holmes-Wright lantern at high brightness in normal room illumination. RESULTS: Screening sensitivity on a single error was found to be 97% compared with the Ishihara plates. Using the Falant scoring method, 20 subjects passed. These were 1 deuteranope, 2 protanomalous trichromats and 17 deuteranomalous trichromats (22% of 88 anomalous trichromats). The mean error score was greater for protans than for deutans but the mean number of qualitative error categories was smaller. Green/white confusions were the most frequent errors. It was not possible to predict who would pass the lantern test from other test results but all subjects with a Nagel anomaloscope matching range > 15 scale units who failed the Farnsworth D15 test or were grading as moderate/severe with the American Optical Company (Hardy, Rand and Rittler) plates failed. CONCLUSIONS: The Holmes-Wright lantern is a sensitive screening test for red-green color deficiency. Although a similar percentage of anomalous trichromats fail the Holmes-Wright lantern as fail the Falant, if the same scoring method is used, the superior correlation between the Holmes-Wright result and other color vision tests designed to grade the severity of color deficiency suggests that the two lantern results are not equivalent.

Adult↗
PubMed1999

Doctors and the assessment of clinical photographs--does colour blindness matter?

Colour vision deficiency (CVD) is a common anomaly, especially in the male population. A group of doctors with CVD was compared with a control group. Doctors with CVD differed from controls in respect of their ability to detect, and in their confidence in the assessment of, abnormalities presented in clinical photographs. These findings suggest that doctors with CVD should take special care to ensure safe clinical practice.

Adult↗
PubMed1999

Performance of red-green color deficient subjects on the Farnsworth Lantern (FALANT).

BACKGROUND: The Farnsworth Lantern (Falant) is an occupational color vision test intended to identify people with significant red-green color deficiency who are unable to name aviation, marine or railway signal lights correctly. The colors shown are white, green and red selected to be within protan and deutan isochromatic zones. HYPOTHESIS: The Falant grades the severity of color deficiency and identifies subjects with different types of deficiency. METHOD: 270 color deficiency subjects (diagnosed with the Neitz anomaloscope) were examined. A subset of 108 subjects also completed the Farnsworth D15 and the Farnsworth-Munsell 100 hue test. RESULTS: All dichromats and 75% of anomalous trichromats failed the Falant. The mean error score of dichromats was greater than that anomalous trichromats, but errors were made in a similar number of qualitative color naming categories. The range of Falant error scores was continuous with no demarkation between the criteria for pass and fail. It was not possible to identify anomalous trichromats likely to pass the Falant from the size of the anomaloscope matching range or from the results of Farnsworth-Munsell tests. CONCLUSIONS: People with severe red-green color deficiency fail the Falant, but neither the type nor the severity of color deficiency can be determined either from the qualitative results or from the error score.

Aviation↗
PubMed1998

Acquired colour deficiency in patients with Parkinson's disease.

The blue cone pathway is reported to be affected early in Parkinson's disease (PD) and acquired type three (tritan) defects may occur. Sixty-one patients attending a treatment and rehabilitation centre for PD were examined with clinical colour vision tests. Seven of 13 patients, for whom the diagnosis of PD was equivocal or who had other medical conditions, were identified as having tritan colour deficiency. Results for the remaining 44 PD patients were compared with 40 age matched controls. Ten PD patients (22.7%) had tritan defects. Tritan defects were not found in the control group but performance on some tests was age related. We conclude that clinical tests for tritan colour deficiency are unlikely to be helpful in identifying PD.

Aged↗
PubMed1998

Blue-yellow colour vision in an onchocercal area of northern Nigeria.

AIM: To determine if the City University Tritan Test is a useful addition to visual function assessment in rural communities in northern Nigeria. METHODS: The study was a cross sectional survey. The participants were 8394 people, aged 5 years and over, living in 37 rural communities, mesoendemic and nonendemic for onchocerciasis, in Kaduna State in northern Nigeria. The main outcome measures were the detection of a defect in blue-yellow colour vision by two criteria: (1) failure with the City University tritan screening plates; (2) failure with the City University grading plates to identify severe tritan defects. RESULTS: 91% of those aged 10 years and above could perform the test. Below this age, there were difficulties in comprehension. The test showed good inter- and intraobserver agreement. After adjustment for confounders the odds of failing the screening plates were significantly increased in the presence of optic atrophy or glaucoma (3.55 (2.48-5.08) and 15.9 (4.22-60.2) respectively). There was a greater increase in the adjusted odds of failing the grading plates in the presence of optic atrophy or glaucoma (5.30 (2.97-9.45) and 8.87 (1.61-48.7) respectively). Cataract had a smaller effect on the screening plates, adjusted odds 1.63 (0.95-2.80). CONCLUSION: Blue-yellow colour vision testing is a useful addition to visual function assessment in those aged 10 years and above in rural northern Nigeria, particularly in the detection of optic nerve disease.

Adolescent↗
PubMed1997

Deficient colour vision and interpretation of histopathology slides: cross sectional study.

OBJECTIVE: To determine whether histopathologists with deficient colour vision make more errors in slide interpretation than those with normal colour vision. DESIGN: Examination of projected transparencies of histopathological slides under standardised conditions by subjects whose colour discriminating ability was accurately assessed. SETTING: Departments of histopathology in 45 hospitals in the United Kingdom. SUBJECTS: 270 male histopathologists and medical laboratory scientific officers. MAIN OUTCOME MEASURES: Number of slides correctly identified by subjects whose colour vision was measured on the Ishihara, City University, and Farnsworth-Munsell 100 hue tests. RESULTS: Mean (SD) scores (out of 10) for doctors with colour deficient vision were 9.4 (0.7) v 9.9 (0.4) for controls (P < 0.01) and 7.5 (1.6) v 9.4 (0.7) for scientific officers (P < 0.001). When subjects with colour deficient vision were categorised into severe, moderate, or mild, there was a significant trend towards those with severe deficiency making more mistakes (P < 0.001). CONCLUSIONS: Histopathologists and medical laboratory scientific officers should have their colour vision tested; if they are found to have a severe protan or deutan deficiency, they should be advised to adopt a safe system of working.

Clinical Competence↗
PubMed1997

Time-resolved X-ray powder diffraction using a large-area CCD-based detector and Rietveld refinement: solid-state polymerization of S2N2 to (SN)x.

A kinetic study of the solid-state polymerization of disulfur dinitride (S2N2) to polysulfur nitride [(SN)x] has been performed, combining monochromatic high-energy (lambda = 0.3263 A) synchrotron radiation X-ray powder diffraction, a large-area (ø = 220 mm) CCD-based X-ray image-intensifier detector and Rietveld refinement. Recently developed techniques for detector calibration and reduction of two-dimensional images to one-dimensional diffraction patterns have been employed for data processing/analysis. Good fits were obtained after Rietveld refinement [Rp = 8.4%, wRp = 9.4%, sin(theta(max))/lambda = 0.585 A(-1)] of diffraction patterns of S2N2 from images with 2 s exposure time. The solid-state polymerization of S2N2 to (SN)x, was followed at a maximum rate of two diffraction images per minute. Scale factors and cell parameters for S2N2 and beta-(SN), as functions of time were readily obtained after Rietveld refinement of the diffraction patterns obtained from each individual image throughout the polymerization. The polymerization was preceded by a lattice distortion of S2N2, and at 50% conversion the a axis had decreased by about 1% and the c axis had increased about 1%. The polymerization yielded not only the expected polymer beta-(SN)x, but also a small amount of a compound that could be another phase of (SN)x.

Journal Article↗
PubMed1997

Clinical use of the American Optical Company (Hardy, Rand and Rittler) pseudoisochromatic plates for red-green colour deficiency.

The efficiency of the American Optical Company (Hardy, Rand and Rittler) (HRR) plates for screening, grading and classifying red-green colour deficiency was examined for 401 male colour deficient subjects previously identified and diagnosed with Nagel anomaloscope. There were 83 protanopes, 30 protanomalous trichromats, 96 deuteranopes and 192 deuteranomalous trichromats. Screening sensitivity was found to be 100% for dichromats and 96.4% for anomalous trichromats based on one screening error (35 subjects, including 7 dichromats, where identified by a single error). Thirty subjects (13.5%) made errors on screening plates only and were identified as having minimal colour deficiency. The HRR grading system did not distinguish dichromats and anomalous trichromats; 54% of dichromats were graded as having moderate rather than severe colour deficiency. Protan/deutan classification was correct for 95% of subjects who failed grading plates. HRR grades for anomalous trichromats were compared with the anomaloscope matching range and with pass or fail of the D15 test. The results show that only two rather than four grading categories can be distinguished by the HRR plates and that both the D15 and the HRR plates are needed in a vocational test battery to establish the severity of colour deficiency.

Color Perception Tests↗
PubMed1997

Efficiency of the Ishihara test for identifying red-green colour deficiency.

The Ishihara test is the most widely used screening test for red-green colour deficiency. Results obtained by 401 people with red-green colour deficiency show that the combined sensitivity of the Transformation and Vanishing plates of the 38 plate Edition of the Ishihara plates is 95.5% on eight errors, 97.5% on six errors and 99.0% on three errors. The Hidden digit designs only identified approximately 50% of colour-deficient subjects. The protan/deutan classification plates were found to be more effective for deutans than for protans. No classification was obtained for 18% of protanopes and 3% of deuteranopes who saw neither figure on classification plates; 40% of protanomalous trichromats and 37.5% of deuteranomalous trichromats saw both classification figures and were classified on the relative luminance (clarity) of these figures. The specificity of the Ishihara test was determined in a previous study (Birch and McKeever, 1993) and the results combined with the present data to obtain the overall efficiency of the Ishihara plates for a representative cross section of colour-deficient subjects.

Adult↗
PubMed1997

Clinical use of the City University Test (2nd Edition).

The City University test (TCU test) aims to identify people with significant colour deficiency and to classify the type of defect. 222 people with congenital red-green colour deficiency, diagnosed with the Nagel anomaloscope, were examined with the TCU test (2nd Edition). All deuteranopes and 44% of deuteranomalous trichromats failed the TCU test. Deutans who failed could be subdivided into two categories of severity depending on whether errors were made on five or more plates. 96% of protanopes and 26% of protanomalous trichromats failed. Protans made fewer errors than deutans and subcategories of severity could not be distinguished according to the number of errors made. The Farnsworth D15 test was found to be more effective than the TCU test in identifying significant protan colour deficiency. Detection and classification rates varied on all the plates of the TCU test. Mixed protan and deutan classification errors were made by 61% of subjects with the majority result correct in 80%. The most efficient plates are identified and recommendations are made for the optimum use of the TCU test in clinical practice.

Color Perception Tests↗